See All Slides - tctmd.com

Slides

Presentation TCT 2012

Top 5 Tips to Make CAS Safer

Presenter: Klaus Mathias

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Presenter: Peter Fitzgerald

October 22, 2012

Presentation TCT 2012

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Presenter: Felix Woitek

October 22, 2012

Presentation TCT 2012

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Presenter: Philippe Genereux

October 22, 2012

Presentation TCT 2012

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Presenter: David Cormode

October 22, 2012

Presentation TCT 2012

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Presenter: Allan Jaffe

October 22, 2012

Advertisement

Slides

Top 5 Tips to Make CAS Safer

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Introduction(14)

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content